Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension

American Journal of Hypertension

Volumn 10, Issue 9 I, 1997, Pages 1064-1068

  Nakano, Y ^a   Oshima, T ^a   Watanabe, M ^a   Matsuura, H ^a   Kajiyama, G ^a   Kambe, M ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme; Angiotensin converting enzyme inhibitor; Essential hypertension; Genetics; Genotype; Polymerase chain reaction

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL;

EID: 0030859402     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00279-3     Document Type: Article

References (28)

1. Vanhoutte PM, Auch-Schwelk W, Biondi ML, et al: Why are converting enzyme inhibitors vasodilators? Br J Clin Pharmacol 1989;28:95S-104S.
2. Ehlers MRW, Riordan JF: Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989;28:5311-5318.
3. Erdos E, Skidgel RA: The angiotensin I-converting enzyme. Lab Invest 1987;56:345-348.
4. Galavaglia GE, Messerli FH, Nunez BD, et al: Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension. Am J Cardiol 1988;62:912-916.
5. Daemen MJAP, Lonbardi DM, Bosman FT, et al: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991; 68:450-456.
6. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (JNC V). Arch Intern Med 1993;153:154-183.
7. Dahlof B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5:95-110.
8. Konstam MA, Rousseau MF, Kronenberg MW, et al: Effects of the angiotensin converting enzyme inhibitor enalapril on the long term progression of left ventricular dysfunction in patients with heart failure. Circulation 1992;86:431-438.
9. Rigat B, Hubert C, Alhenc-Galas F, et al: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the valiance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
10. Tiret L, Rigat B, Visvikis S, et al: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51: 197-205.
11. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644.
12. Heribert S, Hans-Werner H, Stephan RH, et al: Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638.
13. Iwai N, Ohmichi N, Nakamura Y, et al: DD genotype of angiotensin converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994;90:2622-2628.
14. Ukkola O, Savolainen MJ, Salmela PI, et al: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetis mellitus. J Mol Med 1995;73:307-311.
15. Schmidt S, van Hooft IMS, Grobbee DE, et al: Polymorphism of the angiotensin I-converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 1993; 11:345-348.
16. Jeunemaitre X, Lifton RP, Hunt SC, et al: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1992;1:72-75.
17. Postma CT, Dennesen PJW, de Boo T, et al: First dose hypertension after captopril: can it be predicted? A study of 240 patients. J Hum Hypertens 1992;6:205-209.
18. Materson BJ, Reda DJ, Cushman WC, et al: Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Eng J Med 1993;328:914-921.
19. Niutta E, Cusl D, Colombo R, et al: Predicting interindividual variations in antihypertensive therapy: the role of sodium transport system and renin. J Hypertens 1990;8:S53-S58.
20. Rigat B, Hubert C, Corvol P, et al: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1), Nucleic Acids Res 1992;20:1433.
21. Marian AJ, Yu QT, Workman R, et al: Angiotensinconverting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342:1085-1086.
22. Nakai K, Itoh C, Miura Y, et al: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-2202.
23. Saunders E, Weir MR, Kong BW, et al: A comparison of the efficacy and safety of a b-blocker, a calcium channel blocker and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 1990;150:1707-1713.
24. Opsahl JA, Abraham PA, Keane WF: Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease. Cardiovasc Drugs Ther 1990;4: 221-228.
25. Van den Meiracker AH, Man in't Veld AJ, Admiraal PJJ, et al: Partial escape of aniotensin converting enzyme (ACE) inhibition during prolonged CE inhibitor treatment: does it exist and does it affect the antihypertensive response? J Hypertens 1992;10:803-812.
26. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323:27-36.
27. Petretta M, Bonaduce D, Marciano F, et al: Effect of 1 year lisinopril treatment on cardiac autonomic control in hypertensive patients with left ventricular hypertrophy. Hypertension;27(part 1):330-338.
28. Shape N: The effect of ACE inhibition on progression of atherosclerosis. J Cardiovasc Pharmacol 1993;22(suppl 9):9S-12S.